image
Novavax, Inc. NVAX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 5.95
-3.19 %
$ 964 M
Market Cap
-6.13
P/E
INCOME STATEMENT
682 M REVENUE
22.61%
Growth Rates
1Year 22.61%
3Years -15.89%
5Years 105.39%
7Years 55.40%
10Years 36.37%
-249 M OPERATING INCOME
56.06%
Growth Rates
1Year 56.06%
3Years 47.15%
5Years -15.60%
7Years -5.45%
10Years -11.52%
-187 M NET INCOME
65.60%
Growth Rates
1Year 65.60%
3Years 52.45%
5Years -7.16%
7Years -0.29%
10Years -8.50%
EFFICIENCY
Earnings Waterfall Novavax, Inc.
image
Revenue 682 M
Cost Of Revenue 203 M
Gross Profit 479 M
Operating Expenses 728 M
Operating Income -249 M
Other Expenses -61.4 M
Net Income -187 M
700m700m600m600m500m500m400m400m300m300m200m200m100m100m00(100m)(100m)(200m)(200m)(300m)(300m)682m(203m)479m(728m)(249m)61m(187m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
REVENUE
Revenue 682.2 556.4 1 599.0 1 146.3 475.6 18.7 34.3 31.2 15.4 36.2 30.7 20.9 22.1 14.7 0.3 0.3 1.1 1.5 4.7 7.4 8.3 11.8 15.0 24.1 2.5 1.2 0.7 0.5 100 K
GROSS PROFIT
Cost Of Revenue 202.7 343.8 902.6 12.7 747.0 113.8 0 0 237.9 162.6 15.0 8.2 14.7 7.0 0 0 0 0.2 6.5 5.8 3.5 2.1 3.6 4.1 (0.6) (0.4) (0.3) (0.3) (0.3)
Gross Profit 479.4 212.6 696.3 1 133.6 (271.4) (95.2) 34.3 31.2 (222.6) (126.4) 15.7 12.7 7.4 7.7 0.3 0.3 1.1 1.3 (1.8) 1.6 4.8 9.7 11.4 20.0 3.1 1.6 1.0 0.8 0.4
OPERATING INCOME
Operating Expenses 728.4 779.1 1 341.0 2 832.9 892.3 148.3 208.2 202.9 284.5 193.5 99.4 65.1 37.0 29.3 38.8 37.7 35.4 31.6 22.8 10.8 29.2 25.8 33.0 29.3 15.8 6.2 6.2 5.6 5.9
Selling, General and Administrative Expenses 337.2 468.9 488.7 298.4 145.3 34.4 34.4 34.5 46.5 30.8 19.9 14.8 11.0 11.4 10.8 11.9 11.1 14.0 11.3 16.7 33.0 15.7 21.5 18.5 5.9 2.4 2.5 2.4 1.9
Research and Development Expenses 391.2 737.5 1 235.3 2 534.5 747.0 113.8 173.8 168.4 237.9 162.6 79.4 50.3 26.1 17.9 28.0 25.8 24.3 17.6 11.5 5.1 7.4 10.1 11.5 10.8 9.4 3.4 3.4 2.9 3.7
Operating Income (248.9) (566.5) (644.7) (1 686.6) (416.7) (120.6) (173.9) (171.7) (269.1) (157.2) (83.7) (52.4) (29.7) (21.6) (38.5) (37.4) (34.4) (30.3) (24.6) (9.2) (24.5) (16.1) (21.6) (9.3) (12.7) (4.6) (5.2) (4.8) (5.5)
PRE-TAX INCOME
Interest Income Expense 20.1 14.4 19.9 21.1 15.1 12.2 12.2 14.1 13.0 0.2 0.2 0.2 32 K 9 K 9 K 0.5 1.7 1.6 1.5 2.0 1.5 1.2 1.1 0.5 0 0 0 0 0
Total Other Income 72.3 23.5 (8.9) (28.0) (1.5) (12.1) (10.8) (12.1) (10.9) 0.3 0.7 0.5 1.2 2.6 2.3 (1.0) (1.7) 1.7 1.5 (2.0) (1.5) (1.2) (1.1) (0.5) 0 0 0.3 0.2 100 K
Pre-Tax Income (176.6) (543.0) (653.6) (1 714.5) (418.3) (132.7) (184.7) (183.8) (280.0) (156.9) (82.9) (52.0) (28.5) (19.0) (36.2) (38.4) (36.0) (34.8) (23.1) (11.2) (25.9) (17.3) (22.7) (9.7) 0 0 (4.9) (4.6) (5.4)
NET INCOME
Tax Provision 10.9 2.0 4.3 29.2 9.2 (2.6) 1.4 2.3 2.3 (6.4) (5.2) 25 K 77 K 0.4 (0.5) (0.2) 1.7 (0.7) 0 2.0 1.5 0 0 0 (0.6) 100 K (0.4) (0.3) 100 K
Net Income (187.5) (545.1) (657.9) (1 743.8) (427.5) (130.1) (184.7) (183.8) (280.0) (156.9) (82.9) (52.0) (28.5) (19.4) (35.7) (38.4) (36.0) (34.8) (23.1) (11.2) (25.9) (17.3) (22.7) (9.7) (12.2) (4.5) (4.8) (4.5) (5.5)
EPS 1.23 5.41 8.42 23.4 7.43 5.4 9.99 12.6 20.7 12 7.35 6.13 4.33 3.41 6.82 8.97 10.6 11.4 7.86 5.23 14 11.6 18.6 8.6 12.8 6.2 7.72 7.71 10.9